Oncotarget

Research Papers:

N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo

Christoph Kreer _, Janina M. Kuepper, Matthias Zehner, Thomas Quast, Waldemar Kolanus, Beatrix Schumak and Sven Burgdorf

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:6857-6872. https://doi.org/10.18632/oncotarget.14314

Metrics: PDF 1286 views  |   HTML 1660 views  |   ?  


Abstract

Christoph Kreer1, Janina M. Kuepper2, Matthias Zehner1, Thomas Quast1, Waldemar Kolanus1, Beatrix Schumak2,*, Sven Burgdorf1,*

1Life and Medical Sciences (LIMES) Institute, University of Bonn, 53115 Bonn, Germany

2Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, 53105 Bonn, Germany

*These authors have contributed equally to this work

Correspondence to:

Sven Burgdorf, email: burgdorf@uni-bonn.de

Keywords: antigen presentation, Komagataella phaffii, receptor-mediated endocytosis, T cell activation, cross-presentation

Received: May 03, 2016     Accepted: December 05, 2016     Published: December 28, 2016

ABSTRACT

N-glycosylation is generally accepted to enhance the immunogenicity of antigens because of two main reasons. First, the attachment of glycans enables recognition by endocytic receptors like the mannose receptor (MR) and hence increased uptake by dendritic cells (DCs). Second, foreign glycans are postulated to be immunostimulatory and their recognition could induce DC activation. However, a direct comparison between the immunogenicity of N-glycosylated vs. de-glycosylated proteins in vivo and a direct effect of N-glycosylated antigens on the intrinsic capacity of DCs to activate T cells have not been assessed so far.

To analyze whether enforced N-glycosylation is a suited strategy to enhance the immunogenicity of non-glycosylated antigens for vaccination studies, we targeted non-glycoproteins towards the MR by introduction of artificial N-glycosylation using the methylotrophic yeast Komagataella phaffii (previously termed Pichia pastoris). We could demonstrate that the introduction of a single N-X-S/T motif was sufficient for efficient MR-binding and internalization. However, addition of N-glycosylated proteins neither influenced DC maturation nor their general capacity to activate T cells, pointing out that enforced N-glycosylation does not increase the immunogenicity of the antigen per se. Additionally, increased antigen-specific cytotoxic T cell responses in vivo after injection of N-glycosylated compared to de-glycosylated proteins were observed but this effect strongly depended on the epitope tested. A beneficial effect of N-glycosylation on antibody production could not be detected, which might be due to MR-cross-linking on DCs and to concomitant differences in IL-6 production by CD4+ T cells.

These observations point out that the effect of N-glycosylation on antigen immunogenicity can vary between different antigens and therefore might have important implications for the development of vaccines using K. phaffii.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 14314